drugset / Trial / NCT01111630

Study of Erythropoietin (EPO) Administration Schedule

NCT01111630 ↗

Phase 4 Completed 60 enrolled JW Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the hemoglobin and hematocrit variability between once and three times weekly erythropoietin therapy for the anemia in patients with maintenance dialysis.

Timeline

Start
2009-10
Primary completion
2013-10
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator recomon Unknown — —